FDA Inspection 1180699 — Community Blood Center Of Greater Kansas City
The FDA completed an inspection of Community Blood Center Of Greater Kansas City on Sep 27, 2022 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 27, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Kansas City, MO (United States)